Therapeutics

Top Story

VIDEO: Long-term ocular pain requires oral treatment

May 24, 2017

NEPTUNE, N.J. – Anu Laul, OD, FAAO, shares a case of a patient experiencing long-term ocular nerve pain despite healing of the corneal surface after a cleaning device exploded on his face and eyes.

Perspectives on Glaucoma

Systemic β-blockers have little effect on IOP reduction

May 23, 2017
Nonselective systemic -blocker intake showed a clinically relevant association and a borderline significant trend with IOP decrease, while the use of cardioselective…
Meeting News

ARMOR study: Antibiotic resistance high among staphylococci

May 18, 2017
BALTIMORE – Researchers found high levels of antibiotic resistance among staphylococci, along with many isolates demonstrating multidrug resistance, in preliminary…

FDA sets action date for OTC brimonidine drop

May 11, 2017
The FDA has accepted the New Drug Application for brimonidine tartrate ophthalmic solution and set a PDUFA action date for Dec. 27, according to a press release from…
COPE

Diabetic Eye Disease - Volume 2, Number 1

This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.

Diabetic retinopathy (DR) is a major cause of blindness among American adults aged 40 years and older. The prevalence…
More »
Video
Meeting News

VIDEO: Genetic therapies are the future in AMD treatment

March 3, 2017
More »
Featured
Vision Expo East

Vision Expo East

Video

VIDEO: Long-term ocular pain requires oral treatment

May 24, 2017
More »
Video

VIDEO: Long-term ocular pain requires oral treatment

May 24, 2017
NEPTUNE, N.J. – Anu Laul, OD, FAAO, shares a case of a patient experiencing long-term ocular nerve pain despite healing of the corneal surface…

Perspectives on Glaucoma

Systemic β-blockers have little effect on IOP reduction

May 23, 2017
Nonselective systemic -blocker intake showed a clinically relevant association and a borderline significant trend with IOP decrease, while the use of…

Meeting News

ARMOR study: Antibiotic resistance high among staphylococci

May 18, 2017
BALTIMORE – Researchers found high levels of antibiotic resistance among staphylococci, along with many isolates demonstrating multidrug…

FDA sets action date for OTC brimonidine drop

May 11, 2017
The FDA has accepted the New Drug Application for brimonidine tartrate ophthalmic solution and set a PDUFA action date for Dec. 27, according to a…

In the Journals

Steroids in uveitis increase risk for ocular hypertension

May 8, 2017
Patients with noninfectious uveitis are at a high risk of IOP elevation, according to a large retrospective study. Among risk factors…

In the Journals

Vitamin E may sustain ciprofloxacin release in contact lenses

May 3, 2017
Researchers report that vitamin E loading could effectively increase the amount of ciprofloxacin binding in commercial silicone-based soft contact…

In the Journals

Study identifies risk factors for steroid-induced hypertension after PRK

April 28, 2017
Male sex, high myopia, higher central corneal thickness, lower K value, corneal haze, type of steroid used and length of therapy were associated with…

Shire studies SHP640 for infectious conjunctivitis

April 24, 2017
The first U.S. patient has been enrolled in a phase 3 clinical trial for Shire’s SHP640, a combination broad-spectrum antiseptic and…

BLOG: Acquisitions bring new investment, enthusiasm

April 19, 2017
The announcement that Johnson & Johnson acquired Abbott Medical Optics for just more than $4 billion was the latest in a series of acquisitions…

In the Journals

Study shows efficacy of lifitegrast in relieving dry eye symptoms

April 17, 2017
Four weeks of treatment with lifitegrast 5% ophthalmic solution in patients with dry eye disease resulted in subjective relief of symptoms, according…

More Headlines »
Advertisement
Advertisement